Vitamin E analogues as anticancer agents: lessons from studies with alpha-tocopheryl succinate.
about
Drug Delivery Innovations for Enhancing the Anticancer Potential of Vitamin E Isoforms and Their DerivativesVitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogsVitamin E: tocopherols and tocotrienols as potential radiation countermeasuresVitamin E succinate induces apoptosis via the PI3K/AKT signaling pathways in EC109 esophageal cancer cellsSolubility of α-Tocopheryl Succinate in Supercritical Carbon Dioxide Using Offline HPLC-MS/MS Analysis.Anticancer actions of natural and synthetic vitamin E forms: RRR-alpha-tocopherol blocks the anticancer actions of gamma-tocopherol.α-Tocopheryloxyacetic acid: a novel chemotherapeutic that stimulates the antitumor immune response.Vitamin E succinate inhibits survivin and induces apoptosis in pancreatic cancer cellsProtective Macroautophagy Is Involved in Vitamin E Succinate Effects on Human Gastric Carcinoma Cell Line SGC-7901 by Inhibiting mTOR Axis Phosphorylation.Mitochondria: redox metabolism and dysfunction.alpha-Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis.Use of anti-cancer drugs, mitocans, to enhance the immune responses against tumors.alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.α-Tocopheryl succinate induces apoptosis in erbB2-expressing breast cancer cell via NF-κB pathway.Bioanalytical applications using supercritical fluid techniques.Inhibitors of succinate: quinone reductase/Complex II regulate production of mitochondrial reactive oxygen species and protect normal cells from ischemic damage but induce specific cancer cell death.All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.
P2860
Q26824259-1C988112-97D7-44C1-A7C6-2076CB85D772Q28282070-B40FD1B6-2988-4C48-8386-DCEB3EC9123BQ28290335-9DA1CCB3-6D6F-44D9-83E6-F16107522AE4Q28830715-A7CAC16A-AD41-402C-A13B-E14CAC8409C1Q34196081-2FE03371-171E-4FF4-87BF-78A431361320Q34432655-587B34C7-DBAF-4D4B-A6E8-000EC8F4BF45Q35029521-811464FD-0264-4DE1-A1D0-067241CECFF7Q35648915-B494E1C0-6FF5-4DF9-BD25-85D1094CDA0EQ35689588-10E6E01C-5B5F-45FF-A033-CEA5848835A0Q35944831-6E4CBEAB-808D-470E-81AE-6DE9583AB235Q37246682-2827F61A-D123-43FD-84C9-535724D838C0Q37308070-2CBCF8EC-0B25-4D95-9522-7843387B880DQ37387512-3D279299-6720-4433-9209-26DA889CA8A3Q37729171-11BC9D20-BC46-4365-A723-984CEEBBB259Q37810167-7A136D00-303E-4C67-A367-AC077FEB586FQ37921677-D06CEE9B-4BB3-4D88-9872-FE227B3BC2C0Q38617799-06B59A5C-3C00-4F38-8614-B73764C27F7F
P2860
Vitamin E analogues as anticancer agents: lessons from studies with alpha-tocopheryl succinate.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Vitamin E analogues as antican ...... th alpha-tocopheryl succinate.
@ast
Vitamin E analogues as antican ...... th alpha-tocopheryl succinate.
@en
Vitamin E analogues as antican ...... th alpha-tocopheryl succinate.
@nl
type
label
Vitamin E analogues as antican ...... th alpha-tocopheryl succinate.
@ast
Vitamin E analogues as antican ...... th alpha-tocopheryl succinate.
@en
Vitamin E analogues as antican ...... th alpha-tocopheryl succinate.
@nl
prefLabel
Vitamin E analogues as antican ...... th alpha-tocopheryl succinate.
@ast
Vitamin E analogues as antican ...... th alpha-tocopheryl succinate.
@en
Vitamin E analogues as antican ...... th alpha-tocopheryl succinate.
@nl
P2093
P2860
P356
P1476
Vitamin E analogues as antican ...... th alpha-tocopheryl succinate.
@en
P2093
Lanfeng Dong
Marco Tomasetti
Xiu-Fang Wang
P2860
P304
P356
10.1002/MNFR.200500267
P50
P577
2006-08-01T00:00:00Z